First Manhattan Portfolio holdings
AUM
$35.4B
This Quarter Return
+9.64%
1 Year Return
+24.51%
3 Year Return
+86.41%
5 Year Return
+172.47%
10 Year Return
+337.52%
AUM
$27.3B
AUM Growth
+$27.3B
(+4.7%)
Cap. Flow
-$971M
Cap. Flow
% of AUM
-3.56%
Top 10 Holdings %
Top 10 Hldgs %
60.57%
Holding
1,595
New
70
Increased
175
Reduced
500
Closed
162
Top Buys
| 1 |
Thermo Fisher Scientific
TMO
|
$123M |
| 2 |
ATVI
Activision Blizzard Inc.
ATVI
|
$68.7M |
| 3 |
XIFR
XPLR Infrastructure, LP
XIFR
|
$62.2M |
| 4 |
UnitedHealth
UNH
|
$56.2M |
| 5 |
IMGN
Immunogen Inc
IMGN
|
$32.1M |
Top Sells
| 1 |
Berkshire Hathaway Class A
BRK.A
|
$790M |
| 2 |
Amazon
AMZN
|
$78.2M |
| 3 |
AbbVie
ABBV
|
$49.8M |
| 4 |
IAC Inc
IAC
|
$40.9M |
| 5 |
PNC Financial Services
PNC
|
$30.7M |
Sector Composition
| 1 | Financials | 44.09% |
| 2 | Technology | 18.28% |
| 3 | Healthcare | 10.34% |
| 4 | Consumer Discretionary | 7.89% |
| 5 | Communication Services | 5.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Service Corp International
SCI
$10.9B
| $65.8M | 0.24% |
1,018,409
+116,977
| +13% | +$7.56M |
|
52
Pinduoduo
PDD
$177B
| $63M | 0.23% |
911,290
+100,196
| +12% | +$6.93M |
|
53
Capital One
COF
$142B
| $60.8M | 0.22% |
556,265
+15,967
| +3% | +$1.75M |
|
54
Enbridge
ENB
$105B
| $52.6M | 0.19% |
1,416,864
-14,067
| -1% | -$523K |
|
55
Brookfield Asset Management
BAM
$94.4B
| $50.4M | 0.18% |
1,555,467
-416,446
| -21% | -$13.5M |
|
56
Cencora
COR
$57.2B
| $49.5M | 0.18% |
257,160
-599
| -0.2% | -$115K |
|
57
Stryker
SYK
$149B
| $49M | 0.18% |
160,679
-28,500
| -15% | -$8.7M |
|
58
Canadian Natural Resources
CNQ
$65B
| $48.4M | 0.18% |
860,759
-26,391
| -3% | -$1.48M |
|
59
Moody's
MCO
$89B
| $48.2M | 0.18% |
138,602
-2,894
| -2% | -$1.01M |
|
60
IQVIA
IQV
$31.4B
| $43.3M | 0.16% |
192,561
+2,280
| +1% | +$512K |
|
61
Hologic
HOLX
$14.7B
| $41.8M | 0.15% |
516,700
| – | – |
|
62
Meta Platforms (Facebook)
META
$1.85T
| $40.2M | 0.15% |
140,071
-33,170
| -19% | -$9.52M |
|
63
Procter & Gamble
PG
$370B
| $39.5M | 0.14% |
262,858
-9,040
| -3% | -$1.36M |
|
64
Arrowhead Research
ARWR
$3.84B
| $39.2M | 0.14% |
1,099,154
+73,500
| +7% | +$2.62M |
|
65
Ingredion
INGR
$8.2B
| $37.9M | 0.14% |
357,909
-2,936
| -0.8% | -$311K |
|
66
Pfizer
PFE
$141B
| $37.9M | 0.14% |
1,032,055
-43,883
| -4% | -$1.61M |
|
67
JPMorgan Chase
JPM
$824B
| $36.9M | 0.14% |
254,690
-19,792
| -7% | -$2.86M |
|
68
Immunocore
IMCR
$1.78B
| $36.8M | 0.13% |
613,749
| – | – |
|
69
Walt Disney
DIS
$211B
| $36M | 0.13% |
403,497
-64,233
| -14% | -$5.73M |
|
70
Charter Communications
CHTR
$35.7B
| $35.9M | 0.13% |
97,841
+6,581
| +7% | +$2.42M |
|
71
Snap-on
SNA
$16.8B
| $32.7M | 0.12% |
113,324
-3,874
| -3% | -$1.12M |
|
72
Boston Scientific
BSX
$159B
| $32.5M | 0.12% |
600,442
+225
| +0% | +$12.2K |
|
|
IMGN
73
DELISTED
Immunogen Inc
IMGN
| $32.2M | 0.12% |
1,707,500
+1,700,000
| +22,667% | +$32.1M |
|
74
Starbucks
SBUX
$99.2B
| $31.6M | 0.12% |
328,940
-25,099
| -7% | -$2.41M |
|
75
Match Group
MTCH
$9.04B
| $31.3M | 0.11% |
748,769
-86,268
| -10% | -$3.61M |
|